Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 21 | +5 |
| Shares | 1.82M | 1.57M | −259.8K (−14.2%) |
| Value | $2.17M | $973.0K | −$1.20M (−55.1%) |
New holders (5)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belpointe Asset Management LLC | 19,045 | $11.9K | 0.00% |
| Citadel Advisors LLC | 14,607 | $9.09K | 0.00% |
| Ergoteles LLC | 12,687 | $7.89K | 0.00% |
| StoneX Group Inc. | 11,600 | $7.22K | 0.00% |
| Advisory Services Network, LLC | 123 | $77 | 0.00% |
Sold out (0)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
None.